Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections
Qing Lei(Huazhong University of Science and Technology), Xionglin Fan(Huazhong University of Science and Technology), Zhuqing Ouyang(Huazhong University of Science and Technology), Jun‐biao Xue(Shanghai Jiao Tong University), Huan Qi(Qingdao Institute of Bioenergy and Bioprocess Technology), Sheng‐ce Tao(Shanghai Jiao Tong University), Feng Wang(Tongji Hospital), Xuening Wang(Shanxi Medical University), He‐wei Jiang(Shanghai Jiao Tong University), Ziyong Sun, Yandi Zhang(Wuhan Institute of Virology), Hong Chen(Shanghai Sixth People's Hospital), Yang Li(Shanghai Jiao Tong University), Bo Zhang(Tongji Hospital), Zhao‐wei Xu(Shanghai Jiao Tong University), Shenghai Huang(Anhui Medical University), Dan‐yun Lai(Shanghai Jiao Tong University), C.-K. Yu(Tongji Hospital), Shu-Juan Guo(Shanghai Jiao Tong University), Hai‐nan Zhang(Shanghai Jiao Tong University), Yun‐xiao Zheng(Shanghai Jiao Tong University), Xiao‐song Lin(Huazhong University of Science and Technology), Jo‐Lewis Banga Ndzouboukou(Huazhong University of Science and Technology), Hong‐yan Hou(Tongji Hospital), Zongjie Yao(Huazhong University of Science and Technology)
Cited by 138
Related Papers
The laboratory tests and host immunity of COVID-19 patients with different severity of illness
|JCI Insight|2020|576
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
|Clinical & Translational Immunology|2020|415
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
|Cellular and Molecular Immunology|2020|376
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu
|Journal of Clinical Virology|2020|185